Works by Schwartz, Lawrence H


Results: 124
    1
    2
    3
    4

    Artificial intelligence in immunotherapy PET/SPECT imaging.

    Published in:
    European Radiology, 2024, v. 34, n. 9, p. 5829, doi. 10.1007/s00330-024-10637-3
    By:
    • McGale, Jeremy P.;
    • Chen, Delphine L.;
    • Trebeschi, Stefano;
    • Farwell, Michael D.;
    • Wu, Anna M.;
    • Cutler, Cathy S.;
    • Schwartz, Lawrence H.;
    • Dercle, Laurent
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    iRECIST: how to do it.

    Published in:
    2020
    By:
    • Persigehl, Thorsten;
    • Lennartz, Simon;
    • Schwartz, Lawrence H.
    Publication type:
    journal article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Early <sup>18</sup>F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.232827
    By:
    • Aiping Chen;
    • Mokrane, Fatima-Zohra;
    • Schwartz, Lawrence H.;
    • Morschhauser, Franck;
    • Stamatoullas, Apasia;
    • de Colella, Jean-Marc Schiano;
    • Vercellino, Laetitia;
    • Casasnovas, Olivier;
    • Chauchet, Adrien;
    • Delmer, Alain;
    • Nicolas-Virelizier, Emmanuelle;
    • Ghesquières12, , Hervé;
    • Moles-Moreau13, , Marie-Pierre;
    • Schmitt, Anna;
    • Dulery, Rémy;
    • Bouabdallah, Krimo;
    • Borel, Cecile;
    • Touati, Mohamed;
    • Deau-Fischer, Benedicte;
    • Peyrade, Frédéric
    Publication type:
    Article
    37

    <sup>18</sup>F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.

    Published in:
    Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 15, doi. 10.2967/jnumed.117.193011
    By:
    • Dercle, Laurent;
    • Seban, Romain-David;
    • Lazarovici, Julien;
    • Schwartz, Lawrence H.;
    • Houot, Roch;
    • Ammari, Samy;
    • Danu, Alina;
    • Edeline, Véronique;
    • Marabelle, Aurélien;
    • Ribrag, Vincent;
    • Michot, Jean-Marie
    Publication type:
    Article
    38
    39

    Response to Early Treatment Evaluated with <sup>18</sup>F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 5, p. 735, doi. 10.2967/jnumed.115.162412
    By:
    • Joo Hyun O.;
    • Luber, Brandon S.;
    • Leal, Jeffrey P.;
    • Hao Wang;
    • Bolejack, Vanessa;
    • Schuetze, Scott M.;
    • Schwartz, Lawrence H.;
    • Helman, Lee J.;
    • Reinke, Denise;
    • Baker, Laurence H.;
    • Wahl, Richard L.
    Publication type:
    Article
    40
    41
    42
    43
    44

    Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.

    Published in:
    2017
    By:
    • Katz, Matthew H. G.;
    • Fang-Shu Ou;
    • Herman, Joseph M.;
    • Ahmad, Syed A.;
    • Wolpin, Brian;
    • Marsh, Robert;
    • Behr, Spencer;
    • Qian Shi;
    • Chuong, Michael;
    • Schwartz, Lawrence H.;
    • Frankel, Wendy;
    • Collisson, Eric;
    • Koay, Eugene J.;
    • Hubbard, JoLeen M.;
    • Leenstra, James L.;
    • Meyerhardt, Jeffrey;
    • O'Reilly, Eileen;
    • Ou, Fang-Shu;
    • Shi, Qian;
    • Alliance for Clinical Trials on Oncology
    Publication type:
    journal article
    45
    46
    47
    48
    49
    50